A case report of bosutinib-induced interstitial granulomatous drug reaction in a patient with chronic myelogenous leukemia: a case report

Bosutinib is a BCR-ABL tyrosine kinase inhibitor approved for the treatment of Philadelphia chromosome–positive chronic myelogenous leukemia. We report a case of bosutinib-induced interstitial granulomatous drug reaction in a 50-year-old Caucasian female with chronic myelogenous leukemia. Histologic...

Descripción completa

Detalles Bibliográficos
Autores principales: Aria, Alexander B, Chen, Leon, Huen, Auris O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
JCMS Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134482/
https://www.ncbi.nlm.nih.gov/pubmed/30214807
http://dx.doi.org/10.1177/2050313X18795075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134482/
https://www.ncbi.nlm.nih.gov/pubmed/30214807
http://dx.doi.org/10.1177/2050313X18795075

Ejemplares similares